Enteric Oxalate Absorption Study in Unclassified Hyperoxaluria
NCT00588120
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
114
Enrollment
OTHER
Sponsor class
Conditions
Enteric Hyperoxaluria
Hyperoxaluria
Interventions
DRUG:
C-13 labeled oxalate
Sponsor
Mayo Clinic
Collaborators
[object Object]
[object Object]
[object Object]